Astrazeneca Pharma India Limited - Company Profile

It is a pharma public limited company based in Bangalore, Karnataka, India, established in 1979.

1979 Bangalore, Karnataka, India Active

Last Updated: December 22, 2025

About Astrazeneca Pharma India Limited

Astrazeneca Pharma India Limited, a active public limited company, was established on 11 July 1979 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231KA1979PLC003563. Registered under ROC Roc Bangalore. it is listed on BSE: 506820 and NSE: ASTRAZEN. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.

Formerly known as Astra Idl Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,029.07 Cr and a net worth of ₹588.69 Cr. Employing 935 professional, Its leadership includes Revathy Ashok (Director), Hooi Bien Chuah (Director), Bhavana Agrawal (Cfo). Past directors included Sanjeev Kumar Panchal, Nurani Ramachandran Srinivasan, Rajesh Marwaha. It holds no open charges and ₹62.50 Cr settled loans. Its latest AGM occurred on 14 August 2025, with the balance sheet filed on 31 March 2025. It is based at Block N1, 12Th Floor,Manyata Embassy Business Park Rachenahalli, Outer Ring Road, Bangalore, Karnataka, 560045.

Company Details

CIN/LLPIN
L24231KA1979PLC003563
Registration Number
003563
Incorporation Date
11 July 1979
Authorized Capital
₹5.00 Cr
Paid-Up Capital
₹5.00 Cr
ROC Code
Roc Bangalore
Listing Status
Listed (BSE: 506820, NSE: ASTRAZEN)
Company Status
Active

Key Metrics

Authorised Capital ₹ 5.00 Cr as on 22-12-2025
Paid Up Capital ₹ 5.00 Cr as on 22-12-2025
Company Age 46 Year, 8 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 62.50 Cr as on 22-12-2025
Revenue Growth **** 25.44% (FY 2023)
Profit Growth **** 61.19% (FY 2023)
Ebitda **** 91.60% (FY 2023)
Net Worth 15.12% (FY 2023)
Total Assets **** 14.98% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Astrazeneca Pharma India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Astrazeneca Pharma India Limited?

Current Directors

Name	Designation	Appointment Date	Status
Revathy Ashok	Director	02 Dec 2016	Current
Hooi Bien Chuah	Director	09 Nov 2023	Current
Bhavana Agrawal	Cfo	01 Oct 2023	Current
Sylvia Lorena Varela Ramon	Director	21 Dec 2023	Current
Jesus Javier Diaz Ropero Esteso	Director	13 Nov 2024	Current
Monica Widhani	Director	25 Sep 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	01 Jan 2023	Past
Pramod Abcsdd	Company Secretary	31 Jul 2011	Past
Pramod Abcsdd	Additional Director	13 Sep 2017	Past
Pramod Abcsdd	Director	06 Feb 2019	Past
Pramod Abcsdd	Director	02 Dec 2016	Past
Pramod Abcsdd	Director	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Astrazeneca Pharma India.

Astrazeneca Pharma India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.44% increase. The company also saw a substantial improvement in profitability, with a 61.19% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

25.44%

*******

Revenue from Operations

*******

24.50%

*******

Total Assets

*******

14.98%

*******

Profit or Loss

*******

61.19%

*******

Net Worth

*******

15.12%

*******

EBITDA

*******

91.60%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Astrazeneca Pharma India?

In 2023, Astrazeneca Pharma India had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹625,000,000.00

Charges Breakdown by Lending Institutions

Il & Fs Trust Company Limited : 62.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Jan 2008	Il & Fs Trust Company Limited	₹62.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Astrazeneca Pharma India?

Astrazeneca Pharma India has a workforce of 935 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Astrazeneca Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazeneca Pharma India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Astrazeneca Pharma India

Recent Activity within the Organization

Annual General Meeting

The activity Astrazeneca Pharma India Limited last Annual general meeting of members was held on 14 Aug 2025 as per latest MCA records. was completed.
14 Aug 2025
Director Appointment

The activity Praveen Rao Akkinepally was appointed as a Managing Director was appointed as a Managing Director on 01 Jul 2025 & has been associated with this company since 8 months 26 days . was completed.
01 Jul 2025
Balance Sheet

Progress on Astrazeneca Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
31 Mar 2025
Director Appointment

Progress on Jesus Javier Diaz Ropero Esteso was appointed as a Director was appointed as a Director on 13 Nov 2024 & has been associated with this company since 1 year 4 months . was documented.
13 Nov 2024
Director Appointment

Progress on Monica Widhani was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 6 months . was documented.
25 Sep 2024
Director Appointment

The activity Bhavana Agrawal was appointed as a CFO was appointed as a CFO on 15 Mar 2024 & has been associated with this company since 2 years 12 days . was completed.
15 Mar 2024

Explore recent activity and updates - View Recent Activity